EA Series Trust - MRBL Enhanced Equity ETF
EDGE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.84B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.84 Billion |
|---|---|
| Enterprise Value | $1.61 Billion |
| Earnings per Share | $-0.74 |
| Beta | 0.87 |
| Outstanding Shares | 55,660,000 |
Return
| Return on Equity | 1.01% |
|---|---|
| Return on Assets | -0.41% |
| Return on Invested Capital | 228.54% |
Valuation & Multiples
| P/E Ratio | 0.08 |
|---|---|
| PEG | 2.53 |
| Price to Sales | - |
| Price to Book Ratio | -0.79 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.14 |
| Enterprise Value to Net Income | -45 |
| Total Debt to Enterprise | -3.79 |
| Debt to Equity | -1.22 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PDS Biotechnology Corporation
CEO: Frank Bedu-Addo
Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposu...